MMTZF · MindMaze Therapeutics Holding SA
Market Cap
$66.59M
Shares
157.60M
Volume · Oct 22
6057
Avg daily vol (3M)
5492
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.22
Open$0.15
Day$0.15–0.22
52W close$0.16–3.85
Avg vol 30d6K
Short int59K · 0.0% float · 7.8d
Short vol53%
DataJan 2021–Oct 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-94.4%
Trailing year
Short interest
0.0%
Latest settlement · 7.8 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 19 · elevated
Equity put/call 0.69
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−78%
below
Price vs 50-day avg
−4%
below
RSI (14)
52
neutral
MACD trend
Positive
52-week position
2%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−3%
trailing
6-month return
−59%
trailing
YTD return
−91%
this year
Relative strength
−65%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.04% of float · ▲ +16.2% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
55
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
163%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
18.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−78%
Bearish
Price vs 50-day avg
−4%
Neutral
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
2%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.04% of float · ▲ +16.2% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 2%
Range high $4
vs 200-day avg -78%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MMTZF
this stock
MindMaze Therapeutics Holding SA
|
$66.59M | -91.0% | — | — | 0.0% |
|
VRTX
Vertex Pharmaceuticals Inc
|
$133.55B | +15.6% | +46.2% | 30.7 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$84.33B | +4.3% | +20.8% | 20.3 | 2.1% |
|
MRNA
Moderna, Inc.
|
$80.90B | +578.5% | +4.3% | — | 7.7% |
|
CSLLY
Csl Ltd
|
$65.88B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MMTZF | +29.1% | -2.9% | -59.2% | +21.1% | -91.0% |
| SPY | -1.0% | -0.4% | +6.0% | +0.2% | +12.0% |
| vs SPY | +30.1% | -2.5% | -65.3% | +21.0% | -103.0% |